← GILEAD SCIENCES, INC. GILD
Market Price
$138.36
Market Cap
$171.42B
P/E Ratio
20.41
Revenue (FY 2025)
↑2.4% YoY
$29.44B
3-Yr CAGR: 2.6%
Net Income
↑1,672.9% YoY
$8.51B
Net Margin: 28.9%
Free Cash Flow
↓-8.2% YoY
$9.46B
FCF Yield: 5.52%
EPS (Diluted)
↑1,684.2% YoY
$6.78
Basic: $6.84
Return on Equity
Efficiency
37.5%
ROA: 14.4%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (GILD)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $30,390.0M | — | $26,129.0M | $13,501.0M | — | $9.94 | — | $16,669.0M | $15,921.0M | — |
| FY 2017 | $26,107.0M | -14.1% | $21,736.0M | $4,628.0M | -65.7% | $3.51 | -64.7% | $11,898.0M | $11,308.0M | -29.0% |
| FY 2018 | $22,127.0M | -15.2% | $17,274.0M | $5,455.0M | +17.9% | $4.17 | +18.8% | $8,400.0M | $7,476.0M | -33.9% |
| FY 2019 | $22,449.0M | +1.5% | $17,774.0M | $5,386.0M | -1.3% | $4.22 | +1.2% | $9,144.0M | $8,319.0M | +11.3% |
| FY 2020 | $24,689.0M | +10.0% | $20,117.0M | $123.0M | -97.7% | $0.10 | -97.6% | $8,168.0M | $7,518.0M | -9.6% |
| FY 2021 | $27,305.0M | +10.6% | $20,704.0M | $6,225.0M | +4,961.0% | $4.93 | +4,830.0% | $11,384.0M | $10,805.0M | +43.7% |
| FY 2022 | $27,281.0M | -0.1% | $21,624.0M | $4,592.0M | -26.2% | $3.64 | -26.2% | $9,072.0M | $8,344.0M | -22.8% |
| FY 2023 | $27,116.0M | -0.6% | $20,618.0M | $5,665.0M | +23.4% | $4.50 | +23.6% | $8,006.0M | $7,421.0M | -11.1% |
| FY 2024 | $28,754.0M | +6.0% | $22,503.0M | $480.0M | -91.5% | $0.38 | -91.6% | $10,828.0M | $10,305.0M | +38.9% |
| FY 2025 | $29,443.0M | +2.4% | $23,209.0M | $8,510.0M | +1,672.9% | $6.78 | +1,684.2% | $10,019.0M | $9,456.0M | -8.2% |
Valuation
Market Price
$138.36
Market Cap
$171.42B
Enterprise Value
$188.80B
P/E Ratio
20.41
P/B Ratio
7.57
FCF Yield
5.52%
Dividend Yield
2.28%
Shares Outstanding
Profitability & Margins
Gross Margin
78.83%
Operating Margin
34.04%
Net Margin
28.90%
Return on Equity (ROE)
37.48%
Return on Assets (ROA)
14.42%
Asset Turnover
0.50x
Revenue 3-Yr CAGR
2.57%
Financial Health & Liquidity
Current Ratio
0.34
Cash Ratio
0.64
Debt / Equity
1.098
Debt / Assets
0.422
Cash & Equivalents
$7.56B
Total Debt
$24.94B
Book Value / Share
$18.29
Cash Flow Efficiency
Operating Cash Flow
$10.02B
Capital Expenditures (CapEx)
$563.00M
Free Cash Flow
$9.46B
OCF / Revenue
34.03%
FCF / Revenue
32.12%
FCF 3-Yr CAGR
4.26%
Per Share Metrics
EPS (Diluted)
$6.78
EPS (Basic)
$6.84
Dividends / Share
$3.16
Book Value / Share
$18.29
EPS YoY Growth
1,684.21%
Balance Sheet (FY 2025)
Total Assets
$59.02B
Total Liabilities
$59.02B
Stockholders' Equity
$22.70B
Current Assets
$4.02B
Current Liabilities
$11.81B